The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Nanotechnology In Cancer Treatment Market Expected To Reach Based On Its 2026 Value?
The nanotechnology in cancer treatment market size has experienced significant expansion over recent years. Projections indicate its value will escalate from $159.07 billion in 2025 to $183.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.2%. This historical growth can be attributed to several factors, including increasing cancer incidence rates, advancements in nanomaterial engineering, an expansion of oncology research funding, growing collaboration between pharmaceutical and research institutions, and the early clinical success of nano-based therapies.
The nanotechnology in cancer treatment market is poised for substantial growth over the next few years, with its valuation expected to reach $319.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. This projected expansion during the forecast period is fueled by several factors, including the increasing integration of personalized cancer treatment approaches, a surge in investments directed towards nanomedicine research, the broadening scope of clinical trials incorporating nanotechnology, a heightened focus on minimally invasive cancer therapies, and advancements in nano-enabled diagnostics. Prominent developments anticipated in this period include the accelerated creation of nanoparticle-based drug delivery systems, a wider adoption of targeted cancer therapies, the expanding application of multifunctional nanomaterials, the wider implementation of personalized oncology treatments, and a reinforced commitment to mitigating the side effects associated with chemotherapy.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp
What Leading Drivers Are Supporting The Nanotechnology In Cancer Treatment Market Expansion?
The increasing demand for targeted therapies is anticipated to drive the expansion of nanotechnology within the cancer treatment market moving forward. These therapies are defined as cancer treatments designed to pinpoint and attack specific molecular markers or pathways crucial for tumor development and spread. The heightened demand for targeted therapies stems from their capacity to accurately target cancer cells, thereby limiting harm to healthy tissue and lessening adverse effects. Nanotechnology in cancer treatment boosts targeted therapies by facilitating the exact delivery of medications directly to cancerous cells, thereby increasing efficacy and reducing damage to healthy tissues. As an illustration, a report released in July 2023 by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, noted that there were 247 gene therapies in Phase II at the close of Q1 2023, a figure that climbed by 5% to reach 260 by the end of Q2 2023. Consequently, the escalating demand for targeted therapies is a key factor propelling the expansion of nanotechnology in the cancer treatment market.
What Are The Key Segment Divisions In The Nanotechnology In Cancer Treatment Market Segment Structure?
The nanotechnology in cancer treatment market covered in this report is segmented –
1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles
2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types
4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems
5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)
Subsegments:
1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes
2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers
3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles
What Emerging Trends Are Seen In The Nanotechnology In Cancer Treatment Market?
Leading companies operating within the nanotechnology in cancer treatment market are concentrating on developing advanced therapies, such as immunotherapy nano formulation, to improve immune system targeting and minimize adverse effects in cancer patients. This immunotherapy nano formulation utilizes nanotechnology to deliver immune-based treatments directly to target sites, thereby enhancing precision treatment while simultaneously improving drug stability, bioavailability, and immune response activation. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, launched CE120, a broad-spectrum therapeutic cancer nano vaccine that successfully secured Food and Drug Administration clearance. This therapy signifies the first clinical use of platelet membrane-coated nanoparticles for treating solid tumors. CE120 integrates targeted drug delivery with immune system activation, aiming to destroy tumors and prevent recurrence. Its unique nanotechnology platform boosts both therapeutic precision and the immune response. This milestone positions CE120 as a pioneering nanomedicine in cancer treatment.
Which Organizations Are Engaged In The Nanotechnology In Cancer Treatment Market?
Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., Selecta Biosciences Inc., Bind Therapeutics Inc., BlueWillow Biologics Inc., Nanobiomed Inc.
Get The Full Nanotechnology In Cancer Treatment Market Report:
Which Region Leads The Nanotechnology In Cancer Treatment Market In Terms Of Market Share?
North America was the largest region in the nanotechnology in cancer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nanotechnology In Cancer Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Nanotechnology In Cancer Treatment Market 2026, By The Business Research Company
Metal Nanoparticles Market Report 2026
https://www.thebusinessresearchcompany.com/report/metal-nanoparticles-global-market-report
Nanomaterials Market Report
https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report
Nanoparticle Analysis Market Report
https://www.thebusinessresearchcompany.com/report/nanoparticle-analysis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model